Zanubrutinib vs FCR in Fit Treatment-Naive Patients with Chronic Lymphocytic Leukemia: A Matching-Adjusted Indirect Comparison

被引：0
|
作者：
Munir, Talha [1 ]
Mohseninejad, Leyla [2 ]
Xu, Sheng [3 ]
Jevdjevic, Milica [4 ]
Bouwmeester, Walter [4 ]
Yang, Keri [5 ]
机构：
[1] St James Univ Hosp, Dept Haematol, Leeds, W Yorkshire, England
[2] BeiGene Netherlands BV, Schiphol, Netherlands
[3] BeiGene Shanghai Co Ltd, Shanghai, Peoples R China
[4] PRECISIONheor, London, England
[5] BeiGene USA, San Mateo, CA USA
来源：
BLOOD | 2023年 / 142卷
关键词：
D O I：
10.1182/blood-2023-173172
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：3
相关论文
共 50 条
  • [41] Comparative efficacy of nilotinib and dasatinib in newly diagnosed chronic myeloid leukemia: a matching-adjusted indirect comparison of randomized trials
    Signorovitch, James E.
    Wu, Eric Q.
    Betts, Keith A.
    Parikh, Kejal
    Kantor, Evan
    Guo, Amy
    Bollu, Vamsi K.
    Williams, Denise
    Wei, L. J.
    DeAngelo, Daniel J.
    CURRENT MEDICAL RESEARCH AND OPINION, 2011, 27 (06) : 1263 - 1271
  • [42] FCR and Bevacizumab Treatment in Patients With Relapsed Chronic Lymphocytic Leukemia
    Jain, Preetesh
    Lee, Hun Ju
    Qiao, Wei
    Wierda, William
    Benjamini, Ohad
    Burger, Jan
    Ferrajoli, Alessandra
    Estrov, Zeev
    Kantarjian, Hagop
    Keating, Michael
    O'Brien, Susan
    CANCER, 2014, 120 (22) : 3494 - 3501
  • [43] A Comparison of Relative-Efficacy Estimate(S) Derived From Both Matching-Adjusted Indirect Comparisons and Standard Anchored Indirect Treatment Comparisons: A Review of Matching-Adjusted Indirect Comparisons
    Cassidy, Owen
    Harte, Marie
    Trela-Larsen, Lea
    Walsh, Cathal
    White, Arthur
    McCullagh, Laura
    Leahy, Joy
    VALUE IN HEALTH, 2023, 26 (11) : 1665 - 1674
  • [44] Pneumocystis jirovecii Pneumonia in a Treatment-Naive Patient With Chronic Lymphocytic Leukemia
    Strich, Jeffrey R.
    Jerussi, Theresa D.
    Wiestner, Adrian
    Holland, Steven M.
    INFECTIOUS DISEASES IN CLINICAL PRACTICE, 2016, 24 (06) : E86 - E87
  • [45] Unresolved questions in selection of therapies for treatment-naive chronic lymphocytic leukemia
    Bennett, Rory
    Anderson, Mary Ann
    Seymour, John F.
    JOURNAL OF HEMATOLOGY & ONCOLOGY, 2023, 16 (01)
  • [46] Continuous venetoclax in treatment-naive TP53 disrupted patients with chronic lymphocytic leukemia: A chronic lymphocytic leukemia campus study
    Visentin, Andrea
    Mauro, Francesca Romana
    Scarfo, Lydia
    Gentile, Massimo
    Farina, Lucia
    Reda, Gianluigi
    Ferrarini, Isacco
    Proietti, Giulia
    Derenzini, Enrico
    Cibien, Francesca
    Vitale, Candida
    Sanna, Alessandro
    Pietrasanta, Daniela
    Marchetti, Monia
    Murru, Roberta
    Rigolin, Gian Matteo
    Sportoletti, Paolo
    Trimarco, Valentina
    Cavarretta, Chiara Adele
    Angotzi, Francesco
    Cellini, Alessandro
    Ruocco, Valeria
    Zatta, Ivan
    Laurenti, Luca
    Molica, Stefano
    Coscia, Marta
    Ghia, Paolo
    Foa, Robin
    Cuneo, Antonio
    Trentin, Livio
    AMERICAN JOURNAL OF HEMATOLOGY, 2023, 98 (09) : E237 - E240
  • [47] Matching-adjusted indirect comparison of the pelabresib-ruxolitinib combination vs JAKi monotherapy in myelofibrosis
    Gupta, Vikas
    Mascarenhas, John
    Kremyanskaya, Marina
    Rampal, Raajit K.
    Talpaz, Moshe
    Kiladjian, Jean-Jacques
    Vannucchi, Alessandro M.
    Verstovsek, Srdan
    Colak, Gozde
    Dey, Debarshi
    Harrison, Claire
    BLOOD ADVANCES, 2023, 7 (18) : 5421 - 5432
  • [48] Quality-adjusted survival time without symptoms or toxicity of acalabrutinib with or without obinutuzumab in patients with treatment-naive chronic lymphocytic leukemia
    Sharman, Jeff P.
    Miranda, Paulo
    Roos, Jack
    Emeribe, Ugochinyere
    Cai, Ling
    Liljas, Bengt
    Gaitonde, Priyanka
    LEUKEMIA & LYMPHOMA, 2023, 64 (07) : 1243 - 1252
  • [49] Matching-adjusted indirect treatment comparison of ozanimod versus teriflunomide for relapsing multiple sclerosis
    Cohan, Stanley
    Tencer, Tom
    Arndorfer, Stella
    Zhu, Xuelian
    Zivkovic, Marko
    Kumar, Jinender
    MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2021, 52
  • [50] MATCHING-ADJUSTED INDIRECT TREATMENT COMPARISON BETWEEN LANADELUMAB AND BEROTRALSTAT FOR HEREDITARY ANGIOEDEMA PROPHYLAXIS
    Watt, M.
    Malmenas, M.
    Romanus, D.
    Haeussler, K.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2022, 129 : S26 - S26
12345